Skip to main content



Full Schedule

Full Schedule

  • Monday, September 15, 2025
  • 07:15 - 08:15 CEST
    Coffee & Tea
  • 08:15 - 09:40 CEST
    Session 10: Novel Therapies for CLL I: Non-Immunological Approaches
    Co-Chair: Jennifer A. Woyach, MD – Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center
    Co-Chair: Francesc Bosch, MD, PhD – Universtitat Autonoma Barcelona, Hospital Universitari Vall d'Hebron
  • 09:40 - 10:00 CEST
    Morning Break
  • 10:00 - 11:30 CEST
    Session 11: Novel Therapies for CLL II: Harnessing the Power of the Immune System to Combat CLL
    Co-Chair: Arnon P. Kater, MD, PhD – Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, and HOVON
    Co-Chair: Maria Teresa Sabrina Bertilaccio, PhD – The University of Texas MD Anderson Cancer Center
  • 11:30 - 12:20 CEST
    Lunch
  • 12:20 - 12:50 CEST
    Keynote Presentation: Measurable Residual Disease in Chronic Lymphocytic Leukemia: Technical Aspects and Clinical Significance
    Keynote Speaker: Krzysztof Jamroziak, MD, PhD – Medical University of Warsaw
  • 12:50 - 14:05 CEST
    Session 12: Patient Experience and CLL in Resource Limited Countries
    Co-Chair: Anna Schuh, MD, PhD – Churchill Hospital, Oxford University
    Co-Chair: Raúl Gabus, MD – Hospital Maciel, ASSE
  • 14:05 - 14:30 CEST
    Afternoon Break
  • 14:30 - 15:35 CEST
    Session 13: Future Directions and Unmet Needs in CLL
    Co-Chair: Thomas J. Kipps, MD, PhD – UC San Diego, Moores Cancer Center
    Co-Chair: Michael Hallek, MD, PhD – German CLL Study Group, University Hospital of Cologne
  • 14:30 - 15:50 CEST
    Session 13: Future Directions and Unmet Needs in CLL